Table 3.
Control group (n = 40) | Total patient group (n = 69) | |
---|---|---|
Serum sFas (pg/mL) | 2.90 ± 0.91 | 2.86 ± 0.61 |
Follicular fluid sFas (pg/mL) | 2.70 ± 0.61 | 2.54 ± 0.64 |
Serum FasL (ng/mL) | 3.50 ± 1.34 | 3.71 ± 1.57 |
Follicular fluid FasL (ng/mL) | 3.28 ± 1.40 | 3.36 ± 1.64 |
Serum MDA (μM) | 3.99 ± 0.72 | 4.64 ± 1.68* |
Follicular fluid MDA (μM) | 3.47 ± 0.30 | 3.26 ± 0.28** |
Serum SOD (U/mL) | 3.47 ± 0.68 | 3.57 ± 0.94 |
Follicular fluid SOD (U/mL) | 3.14 ± 0.91 | 4.55 ± 1.46* |
Serum TAC (mmol/L) | 1.50 ± 0.48 | 1.85 ± 0.60** |
Follicular fluid TAC (mmol/L) | 1.31 ± 0.63 | 0.82 ± 0.23** |
Data were expressed as mean ± standard error
*p < 0.05, ** p < 0.01